Skip to main content
. 2022 Aug 9;10(9):e1247–e1256. doi: 10.1016/S2214-109X(22)00286-8

Table 1.

Characteristics of participants at 3 months follow-up, South Africa

Female Male Total
Participants 960 (51·3%) 913 (48·8%) 1873 (100%)
Age, years 50 (38–60) 53 (44–63) 52 (41–62)
Age group, years
<40 257 (26·8%) 150 (16·4%) 407 (21·7%)
40–64 539 (56·2%) 563 (61·7%) 1102 (58·8%)
≥65 164 (17·1%) 200 (21·9%) 364 (19·4%)
Ethnicity
Black 515 (53·6%) 381 (41·7%) 896 (47·8%)
White 306 (31·9%) 371 (40·6%) 677 (36·1%)
Mixed 73 (7·6%) 82 (9·0%) 154 (8·2%)
Indian 61 (6·4%) 71 (7·8%) 132 (7·0%)
Asian or other 0 1 (0·1%) 1 (0·1%)
Unknown 5 (0·5%) 8 (0·9%) 13 (0·7%)
Pregnant 31 (3·2%) NA 31 (1·7%)
Number of comorbidities
None 295 (30·7%) 278 (30·4%) 573 (30·6%)
1 303 (31·6%) 310 (34·0%) 613 (32·7%)
2 234 (24·4%) 196 (21·5%) 430 (23·0%)
≥3 128 (13·3%) 129 (14·1%) 257 (13·7%)
Comorbidity and risk factors
Hypertension 330 (34·4%) 339 (37·1%) 669 (35·7%)
Obesity 244 (25·4%) 230 (25·2%) 474 (25·3%)
Diabetes 204 (21·3%) 214 (23·4%) 418 (22·3%)
Heart disease 47 (4·9%) 64 (7·0%) 111 (5·9%)
High cholesterol 43 (4·5%) 61 (6·7%) 104 (5·6%)
HIV 67 (7·0%) 28 (3·1%) 95 (5·1%)
Asthma 58 (6·0%) 34 (3·7%) 92 (4·9%)
Kidney disease 11 (1·1%) 19 (2·1%) 30 (1·6%)
Rheumatological disorder 18 (1·9%) 9 (1·0%) 27 (1·4%)
Cancer 14 (1·5%) 12 (1·3%) 26 (1·4%)
Chronic lung disease 11 (1·1%) 14 (1·5%) 25 (1·3%)
Thyroid disease 20 (2·1%) 4 (0·4%) 24 (1·3%)
Depression 11 (1·1%) 10 (1·1%) 21 (1·1%)
Other 126 (13·1%) 97 (10·6%) 223 (11·9%)
Health sector
Private 687 (71·6%) 724 (79·3%) 1411 (75·3%)
Public 273 (28·4%) 189 (20·7%) 462 (24·7%)
Received supplemental oxygen in hospital 650 (67·7%) 674 (73·8%) 1324 (70·7%)
Admitted to ICU 265 (27·6%) 347 (38·0%) 612 (32·7%)
Received invasive mechanical ventilation 75 (7·8%) 104 (11·4%) 179 (9·6%)
Received at least one dose of a COVID-19 vaccine 478 (49·8%) 464 (50·8%) 942 (50·3%)

Data are n (%) or median (IQR). ICU=intensive care unit. NA=not applicable.